This study aims to develop and test the feasibility of a new therapy called Compassion Focused Therapy (CFT) for psychosis. This therapy helps people with psychosis manage distressing experiences by building internal feelings of safeness and affiliation, and by providing contexts, practices and insights that facilitate the development of compassion to self and others. The focus is on helping people feel safe in relation to their experiences and their social worlds. CFT is a promising new approach that has been successfully provided for people with a range of mental health difficulties. It is also firmly based in the most up-to-date knowledge and science about how the mind works (both normally and under stress). 9 participants will be recruited from NHS psychological therapies services for people with psychosis in South London and Maudsley (SLAM) NHS Foundation Trust. Following a short baseline period they will receive up to 26 weekly sessions (about 6 months) of CFT with a clinical psychologist, and will provide interview and questionnaire research data at five different points during the study. At these assessment points, data will be gathered on participants' experiences, mood, perceptions of their position in the social world, and heart rate variability. The initial therapy protocol has been developed by psychologists with expertise in CFT, alongside people with lived experience of hearing voices and having distressing beliefs. However, it will continue to be developed and evolve as the study progresses, and as more is learnt (e.g. from the service-user participants) about applying the model in this population. At the end of this study, the aim is to have all the information needed to run a randomised controlled trial of this therapy.
Study Type
INTERVENTIONAL
Allocation
NA
Purpose
TREATMENT
Masking
NONE
Enrollment
9
Up to 26 sessions of Compassion Focused Therapy
South London and Maudsley NHS Foundation Trust
London, United Kingdom
Attrition rate measured by number dropping out of therapy
Time frame: 6 months
Psychotic symptoms measured by PSYRATS
Measured by PSYRATS (Psychotic Symptom Rating Scales)
Time frame: Over 6 months of therapy, and 6-8 weeks post-therapy
Depression and anxiety symptoms measured by DASS-21
Measured by DASS-21 (Depression, Anxiety and Stress Scale)
Time frame: Over 6 months of therapy, and 6-8 weeks post-therapy
Subjective wellbeing, symptoms, functioning, and risk/harm measured by CORE
Measured by CORE (Clinical Outcomes in Routine Evaluation)
Time frame: Over 6 months of therapy, and 6-8 weeks post-therapy
Dissociative experiences measured by DES-II
Measured by DES-II (Dissociative Experiences Scale)
Time frame: Over 6 months of therapy, and 6-8 weeks post-therapy
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.